Drugplain

Anubis Barcelona .0165 g/1.5mL

Glycerin, Sorbitol, Aloe Barbadensis Leaf Juice · CONCENTRATE · ANUBIS COSMETICS SL

No Recall History
Plain English

Anubis Barcelona is a concentrate containing glycerin, sorbitol, aloe barbadensis leaf juice at .0165 g/1.5mL, taken topical. Manufactured by ANUBIS COSMETICS SL.

Key Facts

Brand Name
Anubis Barcelona
Generic Name
Glycerin, Sorbitol, Aloe Barbadensis Leaf Juice
NDC Code (Product)
83021-877
Manufacturer
ANUBIS COSMETICS SL
Strength
.0165 g/1.5mL
Dosage Form
CONCENTRATE
Route
TOPICAL
Marketing Status
Application #
M016
Drug Class
Non-Standardized Chemical Allergen [EPC]
Marketing Start
10/19/2022

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

fatigue7 reports
headache7 reports
arthralgia6 reports
insomnia6 reports
drug ineffective5 reports
feeling abnormal5 reports
pain5 reports
anxiety4 reports
weight decreased4 reports
arthritis3 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

NE Lotion Indications

Dosage & Administration

NE Lotion dosage

Warnings

NE Lotion warnings

Frequently Asked Questions

What is Anubis Barcelona used for?

Anubis Barcelona contains Glycerin, Sorbitol, Aloe Barbadensis Leaf Juice. It is a concentrate taken topical. Consult your doctor for specific uses.

Is Anubis Barcelona a controlled substance?

Anubis Barcelona is not classified as a controlled substance by the DEA.

What is the generic name for Anubis Barcelona?

The generic name for Anubis Barcelona is Glycerin, Sorbitol, Aloe Barbadensis Leaf Juice. There are no other listed brand versions of Glycerin, Sorbitol, Aloe Barbadensis Leaf Juice.

What is the NDC code for Anubis Barcelona .0165 g/1.5mL?

The NDC (National Drug Code) for Anubis Barcelona .0165 g/1.5mL is 83021-877, listed by ANUBIS COSMETICS SL.

Product NDC

83021-877

Package NDC

83021-877-07

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)